INS and diabetes mellitus: Visits to endocrinologists and purchases of oral diabetes medication and insulin were associated with a higher risk of mortality (HRs (95% CIs) 1.20(1.07–1.35), 1.35(1.26–1.46) and 3.36(2.92–3.87) respectively).